Armando Anido
2018
In 2018, Armando Anido earned a total compensation of $2M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $289,791 |
|---|---|
| Option Awards | $1,089,232 |
| Salary | $568,218 |
| Other | $53,855 |
| Total | $2,001,096 |
Anido received $1.1M in option awards, accounting for 54% of the total pay in 2018.
Anido also received $289.8K in non-equity incentive plan, $568.2K in salary and $53.9K in other compensation.
Rankings
In 2018, Armando Anido's compensation ranked 5,747th out of 14,244 executives tracked by ExecPay. In other words, Anido earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,747 out of 14,244 | 60th |
Division Manufacturing | 2,177 out of 5,765 | 62nd |
Major group Chemicals And Allied Products | 807 out of 2,128 | 62nd |
Industry group Drugs | 674 out of 1,817 | 63rd |
Industry Pharmaceutical Preparations | 522 out of 1,391 | 63rd |
Source: SEC filing on April 25, 2019.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2018.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019